论文部分内容阅读
目的探讨阿托伐他汀治疗冠心病合并高脂血症的临床疗效。方法选择我院56例冠心病合并高脂血症患者,按随机数表达法分为对照组与实验组,各28例。对照组给予常规药物治疗,实验组在常规治疗的基础上加用阿托伐他汀治疗,比较两组治疗效果。结果治疗8周后,实验组治疗总有效率92.86%,显著高于对照组75.0%,差异具有统计学意义(P<0.05);两组不良反应几率比较,无显著差异(P>0.05)。结论阿托伐他汀治疗冠心病合并高脂血症具有一定的有效性和安全性,值得推广及应用。
Objective To investigate the clinical efficacy of atorvastatin in the treatment of coronary heart disease complicated with hyperlipidemia. Methods 56 cases of coronary heart disease with hyperlipidemia in our hospital were randomly divided into control group and experimental group according to random number expression method, with 28 cases in each group. The control group was given conventional drug therapy. The experimental group was treated with atorvastatin on the basis of routine treatment, and the treatment effect was compared between the two groups. Results After 8 weeks of treatment, the total effective rate of the experimental group was 92.86%, which was significantly higher than that of the control group (75.0%), the difference was statistically significant (P <0.05). There was no significant difference between the two groups in adverse reaction rate (P> 0.05). Conclusion Atorvastatin treatment of coronary heart disease with hyperlipidemia has a certain effectiveness and safety, it is worth promoting and application.